37 studies found for:    Open Studies | "Blindness"
Show Display Options
Rank Status Study
21 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
22 Unknown  GLP Analogs for Diabetes in Wolfram Syndrome Patients
Conditions: Diabetes Mellitus Associated With Genetic Syndrome;   Wolfram Syndrome
Intervention: Drug: Exenatide
23 Recruiting Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Usher Syndrome Type 2;   Usher Syndrome Type 3
Intervention: Drug: NT-501
24 Recruiting Assess the Efficacy/Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Choroidal Neovascularization.
Condition: Choroidal Neovascularization (CNV)
Interventions: Drug: Ranibizumab;   Other: Sham control
25 Recruiting Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
Conditions: Non-exudative Age-related Macular Degeneration;   Diabetic Retinopathy;   Retina Vein Occlusion;   Retinitis Pigmentosa;   Hereditary Macular Degeneration
Intervention: Drug: CD34+ bone marrow stem cells intravitreal
26 Recruiting Patient Registry of Blind Subjects With Sleep-related Problems
Condition: Sleep-wake Disorder in Blind Individuals
Intervention: Other: Data collection on blindness and sleep problems
27 Recruiting Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
Condition: Non 24 Hour Sleep Wake Disorder
Intervention: Drug: tasimelteon
28 Recruiting Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Condition: Non-24-Hour Sleep-Wake Disorder
Intervention: Drug: tasimelteon
29 Recruiting Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
Condition: Idiopathic Intracranial Hypertension
Intervention: Drug: AZD4017
30 Recruiting Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinitis Pigmentosa;   Retinal Degeneration
Intervention: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
31 Recruiting PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Condition: Anterior Ischemic Optic Neuropathy
Intervention: Drug: Diagnostic procedures
32 Recruiting Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept
33 Unknown  Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Drug: Tissue Plasminogen Activator
34 Recruiting Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Condition: Age Related Macular Degeneration
Intervention: Drug: Ranibizumab
35 Recruiting OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: OZURDEX
36 Unknown  Second Line Therapy to Treat Age-Related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself
Condition: Age Related Macular Degeneration
Interventions: Drug: Visudyne;   Drug: Lucentis;   Drug: Dexamethasone
37 Unknown  Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years